Gelonghui (600329.SH) announced on November 22|Da Rentang () announced that it recently received the “Notice Letter on Changes in the Shareholding Structure of Pharmaceutical Group” from the controlling shareholder, Tianjin Pharmaceutical Group Co., Ltd., which adjusted the original pharmaceutical group equity transfer plan according to the overall deployment and strategic planning arrangements of the superior units of the pharmaceutical group's shareholders. The equity structure of the Pharmaceutical Group has changed, and the registration of industrial and commercial changes in equity matters has been completed. Tianjin Bohai Guoxin Technology Co., Ltd., a shareholder of Pharmaceutical Group, used its 33% stake in Pharmaceutical Group to increase capital to Tianjin Guoyu Enterprise Management Co., Ltd., a wholly-owned subsidiary of Tianjin Guoyu Enterprise Management Co., Ltd.
The current change in the shareholding structure of the controlling shareholder of the company will not cause changes in the number of shares held by the company and the shareholding ratio of the company, nor will it cause changes in the controlling shareholders and actual controllers of the company. The controlling shareholder of the company is still the pharmaceutical group, and the company still has no actual controller.